Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo
Journal article published in 2021 by
Franziska Briest 
,
Eva J. Koziolek,
Jakob Albrecht,
Fränze Schmidt,
Monique R. Bernsen ,
Joost Haeck,
Anja A. Kühl,
Dagmar Sedding,
Teresa Hartung,
Samantha Exner ,
Martina Welzel,
Christian Fischer,
Carsten Grötzinger ,
Winfried Brenner,
Richard P. Baum
and other authors.
,
Eva J. Koziolek,
Jakob Albrecht,
Fränze Schmidt,
Monique R. Bernsen ,
Joost Haeck,
Anja A. Kühl,
Dagmar Sedding,
Teresa Hartung,
Samantha Exner ,
Martina Welzel,
Christian Fischer,
Carsten Grötzinger ,
Winfried Brenner,
Richard P. Baum
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 